CoChat

Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

alpha-Synucleinopathies are neurodegenerative disorders that range pathologically from the demise of select groups of nuclei to pervasive degeneration throughout the neuraxis. Although mounting evidence suggests that alpha-synuclein lesions lead to neurodegeneration, this remains controversial. To explore this issue, we generated transgenic mice expressing wild-type and A53T human alpha-synuclein in CNS neurons. Mice expressing mutant, but not wild-type, alpha-synuclein developed a severe and complex motor impairment leading to paralysis and death. These animals developed age-dependent intracytoplasmic neuronal alpha-synuclein inclusions paralleling disease onset, and the alpha-synuclein inclusions recapitulated features of human counterparts. Moreover, immunoelectron microscopy revealed that the alpha-synuclein inclusions contained 10-16 nm wide fibrils similar to human pathological inclusions. These mice demonstrate that A53T alpha-synuclein leads to the formation of toxic filamentous alpha-synuclein neuronal inclusions that cause neurodegeneration.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0896-6273(02)00682-7

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. Duda, 2002, Novel antibodies to oxidized α-synuclein reveal abundant neuritic pathology in Lewy body diseases, Ann. Neurol., in press

Cited by

See all 1,266

Metadata

Authors
Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y.
Affiliations
  • University of Pennsylvania (US)
  • Veterans Health Administration (US)
Corresponding author
Lee, Virginia M.-Y.
Venue
Neuron
Publisher
Elsevier BV
Published
2002-05
Volume
34
Issue
4
Pages
521-533
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2092791231
Cited by
1,266
References
53
Citations by year
2026: 55 · 2025: 60 · 2024: 77 · 2023: 49 · 2022: 63 · 2021: 73 · 2020: 69 · 2019: 55 · 2018: 58 · 2017: 63 · 2016: 36 · 2015: 30 · 2014: 49 · 2013: 53 · 2012: 45
FWCI
36.72
Type
journal article
Language
en
Open access
Locations
  • Neuron (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Canadian Institutes of Health Research
  • National Institutes of Health
  • Alzheimer's Association
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
synucleinopathies, A53T alpha-synuclein, transgenic mice, neurodegeneration, motor impairment, neuronal inclusions, alpha-synuclein fibrils, Parkinson's disease
MeSH terms
Animals, Axons, Behavior, Animal, Brain, Inclusion Bodies, Disease Models, Animal, Female, Gene Expression Regulation, Humans, Male, Mice, Transgenic, Microscopy, Electron, Movement Disorders, Nerve Tissue Proteins, Neurons, Phenotype, Recombinant Fusion Proteins, Solubility, Spinal Cord, Wallerian Degeneration, Neurodegenerative Diseases, Mice, Synucleins, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein. https://app.cochat.ai/papers/10.1016/s0896-6273(02)00682-7
The paper
Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002). Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein. Neuron. https://doi.org/10.1016/s0896-6273(02)00682-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.